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Abstract. Eight polyhydroxylated cholesterol derivatives (1-8) were prepared from cholesterol, 
using oxidative reagents as SeO2, OsO4/NMO, HCOOH/H2O2 and BH3/H2O2. Their structures 
were elucidated by using physical methods including NMR 1D and 2D. These compounds were 
evaluated against two cancer cell lines (Hep-G2, T98). Compounds 2, 4 and 8 inhibit human 
hepatocellular carcinoma cell line (Hep-G2) with IC50 values of 11.59, 11.89 and 6.87 µM, 
respectively. In addition, compound 8 exhibited strong cytotoxicity against T98 cell line 
(glioblastoma) with IC50 = 2.28 µM. 
Keywords: cholesterol, cytotoxicity, polyhydroxylated derivative. 
Classification numbers: 1.1.2, 1.4.1. 
1. INTRODUCTION 
Polyhydroxylsteroids or oxysterols are oxygenated derivatives of steroids and constitute a 
family of compounds with various biological activities. Especially, oxysterols have been shown 
to exhibit cytotoxicity in a number of cell lines, including smooth muscle cells, fibroblasts and 
vascular endothelial cells [1]. This steroidal compound class exhibits very good activities for 
certain diseases such as muscular dystrophy and cancer [2, 3]. Oxysterols, like steroid hormones, 
have specific physiological properties and deregulation of their metabolism is associated with 
several pathologies including cancer. Some oxysterol metabolic pathways represent novel targets 
for the development of anticancer agents [4].  
Herein, we report the preparation of eight polyhydroxysteroids from cholesterol by using 
one or combination of several oxidative reagents such as SeO2, OsO4/NMO, HCOOH/H2O2 
(Figure 1) and BH3/H2O2 and their cytotoxicity evaluation on 2 cancer cell lines as Hep-G2 and 
T98.  
2. MATERIALS AND METHODS 
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General: All reagents and solvents were purchased from Sigma-Aldrich, Acros and 
Merck and used without pre-purification. NMR spectra were recorded on a Bruker Avance 500 
(Germany) spectrometer using TMS as internal standard. MS spectra and HPLC were recorded 
on a LC-MS Agilent 1100 (USA). Melting points (m. p) were recorded on a Buchi B-545 
apparatus. All reactions were monitored by thin layer chromatography (TLC) using silica gel 60 
coated plates F254 (aluminum sheets). Visualization was performed by UV at 254 and 365 nm. 
Chemical shifts are reported in δ/ppm relative to the external standards and coupling constants J 
are given in Hz. Abbreviations for the characterization of the signals: s = singlet, d = doublet, t = 
triplet, quint = quintet, m = multiplet, bs = broad singlet, dd =  doublet doublet, dt = doublet 
triplet. 
Bioassays: The in vitro cytotoxicity of compounds were tested on the Hepatocellular 
carcinoma (Hep-G2) cell line at the Institute of Natural Product Chemistry (INPC) and on T98 
cell line at Korean Institute of Science and Technology Gangneung (KIST). Cytotoxicity assay 
was performed based on the method of Skehan et al. [5] and Likhiwitayawuid et al. [6] using 
suforhodamine B (SRB). Hep-G2 cell line was cultured in 10 % FBS-DMEM (Fetal Bovine 
Serum - Dulbecco’s Modified Eagle Medium) and incubated in 5 % CO2 and 95 % air at 37 0C 
for 3 days. The fresh cells were treated with trypsin at 37 0C for 5 min and were resuspended in a 
fresh medium containing 10 % FBS to a density of 1x104 cells/mL. For activity assay, in 
triplicate 96-well plates 190 µL of the cell suspension was added in each well which contained 
10 µL of test samples with various known concentration prepared in 5 % DMSO. Ellipticine was 
used as the positive reference. The cultured plates were then incubated for 3 days and cells were 
fixed with 100 µL of 30 % trichloroacetic acid for 30 min at 4 0C. Unbound protein was 
removed gently under tap water and the plates were stained for 30 min with 200 µL of 0.4 % 
SRB (w/v)  in 1% acetic acid. Unbound dye was removed by four washes with 200 µL of 1 % 
acetic acid. The stained bound protein was then dissolved in 200 µL of 10 mM un buffered Tris 
base (tris(hydroxymethyl)aminomethane) and the optical density was measured in a computer-
interfaced, 96-well microplate reader at A540 nm. The SRB assay results were linear with the 
number of cells and with values for cellular protein measured at densities ranging from sparse 
subconfluent to multilayered supraconfluent. The signal-to-noise ratio at 515-564 nm was 
approximately 1.5 with 1,000 cells per well. 
Preparation of 1 and 2: 1M BH3 in THF (7 mL 7.0 mM) was added slowly to a solution of 
cholesterol (540 mg, 1.4 mM) in dry THF (8 mL) under inert atmosphere at 0 oC. The mixture 
was stirred at room temperature for 4h. Aqueous solution of NaOH (5N, 1.5 mL, 7.5 mM) and 
30 % H2O2 (0.75 mL, 6.5 mM) were added drop-by-drop at 0oC. The reaction mixture was 
stirred at room temperature for 1h and then concentrated under reduced pressure. The residue 
was extracted with ethyl acetate (3 × 15 mL). The combined organic layers were washed 
successively with 1N HCl, saturated NaHCO3 solution and brine, dried over Na2SO4, filtered and 
evaporated in vacuo. The residue was purified by column chromatography of silica gel 
(DCM/MeOH 100:1) to yield compounds 1 (402 mg, 71 %) and 2 (50 mg, 9 %).  
Cholestane-3β,6α-diol (1): white needles; m. p.
 
191-193 oC; 1H NMR (500 MHz, CDCl3-
d4) δH (ppm): 3.55 (1H, m, H-3), 3.39 (1H, ddd, J = 4.5, 10.5, 11.0 Hz, H-6), 0.90 (3H, d, J = 6.5 
Hz, CH3-21), 0.86 (6H, d, J = 6.5 Hz, CH3-26, CH3-27), 0.80 (3H, s, CH3-19), 0.65 (3H, s, CH3-
18); 13C NMR (125 MHz, CDCl3-d4) δC (ppm): 71.1 (C-3), 69.4 (C-6), 56.2 (C-14), 56.18 (C-5), 
53.8 (C-17), 51.6 (C-9), 42.6 (C-13), 41.5 (C-4), 39.8 (C-12), 39.5 (C-24), 37.3 (C-1), 36.3 (C-
10), 36.1 (C-22), 35.7 (C-20), 34.3 (C-8), 32.1 (C-7), 30.8 (C-2 ), 28.1 (C-16), 28.0 (C-25), 24.2 
(C-15), 23.8 (C-23), 22.8 (C-26), 22.5 (C-27), 21.1 (C-11), 18.6 (C-19), 13.4 (C-21), 12.0 (C-
18).  
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Cholestane-3β,6β-diol (2): white needles; m. p. 212-215 oC; 1H NMR (500 MHz, CDCl3-d4) δH 
(ppm): 4.09 (1H, br, H-6), 3.70 (1H, br, H-3), 0.68 (3H, s, CH3-18), 0.86 (6H, d, J = 6.5 Hz, 
CH3-26, CH3-27), 0.91 (3H, d,  J = 6.5 Hz, CH3-21), 1.14 (3H, s, CH3-19); 13C NMR (125 MHz, 
CDCl3-d4) δC (ppm): 73.3 (C-3), 66.2 (C-6), 56.5 (C-17), 56.4 (C-14), 43.6 (C-9), 42.8 (C-13), 
40.2 (C-10), 40.1 (C-12), 39.5 (C-24), 36.2 (C-1), 35.8 (C-20),  34.8 (C-8), 34.4 (C-7), 33.6 (C-
5), 30.6 (C-2), 30.1 (C-22), 28.3 (C-16), 28.0 (C-25), 26.1 (C-23), 24.2 (C-15), 23.8 (C-19), 22.8 
(C-26), 22.5 (C-27), 20.9 (C-11), 18.7 (C-21), 12.1 (C-18).  
Preparation of 3, 4 and 5: SeO2 (0.516 g, 4.64 mM) was added to a solution of cholesterol 
(1 g, 2.58 mM) in dioxane (20 mL) and water (0.1 mL) at room temperature and the reaction 
mixture was heated and stirred at 80 oC for 80 h. After filtering and evaporating the solvent 
under reduced pressure, the residue was dissolved in DCM and distilled water. The organic layer 
was separated, dried with Na2SO4 and filtered. After evaporating of solvent, the crude product 
was purified by flash chromatography (SiO2, n-hexane/ethyl acetate 9:1) to yield compounds 3 
(500 mg, 50 %), 4 (35 mg, 3.5 %) and 5 (20 mg, 2 %). 
Cholestan-5-ene-3β,4β-diol (3): white solid; m. p. 175-178 oC; 1H NMR (500 MHz, 
CDCl3-d4) δH (ppm): 5.68 (1H, m, H-6), 4.13 (1H, d, J = 3.0 Hz, H-4), 3.56 (1H, dt, J = 4.0, 11.5 
Hz, H-3), 1.18 (3H, s, CH3-19), 0.92 (3H, d, J = 6.5 Hz, CH3-21), 0.86-0.87 (6H, d, J = 7.0 Hz, 
CH3-26, CH3-27), 0.68 (3H, s, CH3-18); 13C NMR (125 MHz, CDCl3-d4) δC (ppm): 142.8 (C-5), 
128.8 (C-6), 77.3 (C-4), 72.3 (C-3), 56.9 (C-17), 56.1 (C-14), 50.2 (C-9), 42.3 (C-13), 39.7 (C-
12), 39.5 (C-24), 36.9 (C-1), 36.2 (C-22), 36.0 (C-10), 35.8 (C-20), 32.1 (C-8), 31.8 (C-7), 28.2 
(C-15), 28.0 (C-25), 25.4 (C-16), 24.3 (C-2), 23.8 (C-23), 22.8 (C-26), 22.6 (C-27), 21.1 (C-11), 
20.6 (C-19), 18.7 (C-21), 11.9 (C-18) .  
Cholestan-5-ene-3β,4β,7β-triol (4): white solid; m. p. 190-192 oC; 1H NMR (500 MHz, 
CDCl3-d4) δH (ppm): 5.87 (1H, d, J = 5.0 Hz, H-6), 4.18 (1H, d, J = 3.0 Hz,  H-4), 3.94 (1H, d,             
J = 3.5 Hz, H-7), 3.60 (1H, m, H-3), 2.01 (1H, ddd, J = 3.0, 3.5, 2.5 Hz, H-12), 1.18 (3H, s, 
CH3-19), 0.93 (3H, d, J = 6.5 Hz, CH3-21), 0.86-0.87 (6H, d, J = 6.5 Hz, CH3-26, CH3-27), 0.69 
(3H, s, CH3-18); 13C NMR (125 MHz, CDCl3-d4) δC (ppm): 147.0 (C-5), 129.7 (C-6), 76.9 (C-4), 
72.1 (C-3), 65.3 (C-7), 55.8 (C-17), 49.3 (C-14), 42.6 (C-9), 42.1 (C-13), 39.5 (C-24), 39.1 (C-
12), 37.6 (C-8), 37.0 (C-10), 36.7 (C-1), 36.2 (C-22), 35.8 (C-20), 28.3 (C-15), 28.0 (C-25), 25.1 
(C-16), 24.3 (C-2), 23.7 (C-23), 22.8 (C-26), 22.6 (C-27), 20.1 (C-11), 19.4 (C-19), 18.7 (C-21), 
11.6 (C-18).  
Cholestan-5-ene-3β,7β-diol (5): white solid; m. p. 178-180 oC; 1H NMR (500 MHz, 
CDCl3-d4) δH (ppm):  5.60 (1H, m, H-6), 3.84 (1H, m, H-7), 3.58 (1H, m, H-3), 0.99 (3H, s, 
CH3-19), 0.92 (3H, d, J = 6.5 Hz, CH3-21), 0.86-0.87 (6H, d, J = 6.5 Hz, CH3-26, CH3-27), 0.68 
(3H, s, CH3-18);  13C NMR (125 MHz, CDCl3-d4) δC (ppm): 146.3 (C-5), 123.9 (C-6), 71.4 (C-
3), 65.4 (C-7), 55.9 (C-17), 49.4 (C-14), 42.3 (C-9), 42.2 (C-13), 42.0 (C-4), 39.5 (C-24), 39.2 
(C-12), 37.5 (C-8), 37.4 (C-10), 37.0 (C-1), 36.2 C-22), 35.8 (C-20), 31.4 (C-16), 28.3 (C-15), 
28.0 (C-25), 24.3 (C-2), 23.7 (C-23), 22.8 (C-26), 22.6 (C-27), 20.7 (C-11), 18.8 (C-21), 18.3 
(C-19), 11.6 (C-18). 
Cholestane-3β,5α,6α-triol (6): 4-Methylmorpholine N-oxide (150 mg, 1.28 mM) and a 4 
% aqueous solution of OsO4 (300 µL, 0.05 mM) were added to a solution of cholesterol (0.258 
mM) in a dioxane:H2O (50:1) mixture (5 mL). The reaction mixture was stirred under reflux for 
48 h and cooled to room temperature, 20 % NaHSO3 solution (5 mL) was added. The mixture 
was stirred for more 10 min and concentrated. The residue was extracted with ethyl acetate (5 x 
10 mL). The combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash chromatography on silica gel using DCM/MeOH (99:1) as eluent 
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to give cis-dihydroxylated product 6 as a white solid (74%), m. p. 240-241 oC. 1H NMR (500 
MHz, CDCl3-d4) δH (ppm):  4.05 (1H, m, H-3), 3.67 (1H, d like, J = 10.0 Hz, H-6), 2.14 (2H, dd, 
J = 13.0, 3.5 Hz, H-4), 1.53 (1H, m, H-25), 0.96 (3H, s, CH3-19), 0.90 (3H, d, J = 6.5 Hz, CH3-
21), 0.86 (6H, d, J = 6.5 Hz, CH3-26, CH3-27), 0.64 (3H, s, CH3-18); 13C-NMR (125 MHz, 
CDCl3-d4) δC (ppm): 76.7 (C-5), 70.6 (C-6), 67.5 (C-3), 56.2 (C-14), 55.9 (C-17), 44.6 (C-9), 
42.7 (C-13), 39.8 (C-12), 39.5 (C-24), 39.1 (C-10), 38.3 (C-4), 36.1 (C-22), 35.8 (C-20), 35.2 
(C-7), 33.5 (C-8), 31.0 (C-1), 30.6 (C-2), 28.2 (C-16), 28.0 (C-25), 24.1 (C-15), 23.9 (C-23), 
22.8 (C26), 22.5 (C-27), 21.2 (C-11), 18.6 (C-21), 15.5 (C-19), 12.1 (C-18).  
Cholestan-3β,4β,5α,6α-tetrol (7): cis-dihydroxylation procedure by OsO4/NMO of 3 as 
above described. Compound 7 was obtained as white needles (78%). 1H NMR (500 MHz, 
MeOD-d4 & CDCl3-d4) δH (ppm): 4.11 (1H, dd, J = 5.0, 11.5 Hz, H-6), 4.00 (1H, ddd, J = 4.0, 
4.5, 11.5 Hz,  H-3), 3.89 (1H, d, J = 3.5 Hz, H-4), 0.92 (3H, d, J = 6.5 Hz, CH3-21), 0.87-0.88 
(6H, d, CH3-26, CH3-27), 0.68 (3H, s, CH3-18); 13C NMR (125 MHz, MeOD-d4 & CDCl3-d4) δC 
(ppm): 78.0 (C-5), 72.6 (C-4), 69.3 (C-3), 67.8 (C-6), 57.4 (C-14), 57.3 (C-17), 46.5 (C-9), 43.7 
(C-13), 41.1 (C-12), 40.5 (C-24), 39.8 (C-10), 37.2 (C-22), 36.9 (C-20), 35.3 (C-7), 34.8 (C-8), 
32.3 (C-1), 29.1 (C-16), 28.9 (C-25), 26.3 (C-2), 25.0 (C-15), 24.8 (C-23), 23.1 (C-26), 22.9 (C-
27), 21.3 (C-11), 19.1 (C-21), 15.5 (C-19), 12.5 (C-18).  
Cholestane-3β,5α,6β-triol (8): Formic acid 88 % (2 mL) was added to a solution of 
cholesterol (200 mg, 0.516 mM) in dry THF (4 mL) and the mixture was heated at 40-45 oC,             
30 % hydrogen peroxide (0.6 mL) was added slowly and the mixture was stirred for 12 h at 
room temperature. Ethyl acetate (15 mL) and water (10 mL) was added then organic layer was 
separated. Extraction of aqueous layer with ethyl acetate (3 x 10 mL) and combined organic 
layers were washed with 10 % NaHCO3, 5 % NaOH, brine, and water, dried over anhydrous 
Na2SO4, filtered, and concentrated. The residue was heated under reflux with 3 % KOH solution 
in MeOH (15 mL) for 15 min, and evaporated under reduced pressure. The crude product was 
purified by column chromatography (SiO2, DCM/MeOH 19:1) to give a white solid (8) (160 mg, 
75 %), m. p. 231 oC. 1H NMR (500 MHz, CDCl3-d4) δH (ppm): 4.05 (1H, m, H-3), 3.49 (1H, bs, 
H-6), 0.90 (3H, d, J = 6.5 Hz, CH3-21), 0.86 (6H, d, J = 6.5 Hz, CH3-26, CH3-27), 0.68 (3H, s, 
CH3-18). 13C NMR (125 MHz, CDCl3-d4) δC (ppm): 76.0 (C-6), 75.7 (C-5), 67.5 (C-3), 56.3 (C-
14), 56.0 (C-17), 45.8 (C-9), 42.8 (C-13), 40.3 (C-4), 40.0 (C-12), 39.5 (C-24), 38.3 (C-10), 36.2 
(C-22), 35.8 (C-20), 34.3 (C-7), 32.4 (C-1), 30.6 (C-2), 30.3 (C-8), 28.3 (C-16), 28.0 (C-25), 
24.2 (C-15), 23.9 (C-23), 22.8 (C-26), 22.6 (C-27), 21.2 (C-11), 18.7 (C-21), 16.8 (C-19), 12.2 
(C-18).  
3. RESULTS AND DISCUSSION 
The oxidation reaction on cholesterol using BH3.THF/H2O2 agent gave 2 stereoisomers: 
cholestane-3β,6α-diol (1) and cholestane-3β,6β-diol (2) with ratio 8:1. The 1H NMR spectrum of 
1 and 2 showed the appearance of proton signals at δH 3.39 (H-6) in 1 and 4.09 (H-6) in 2 which 
correspond to oxygenated CH groups. Compound 1 was previously reported being isolated from 
the starfish Acanthaster planci [7]. 
While treating cholesterol with SeO2 at 80 oC for 18 h using the reported procedure for 
diosgenin [8, 9] only compound 3 was obtained. However, increasing of heating period to 80 h 
leads to the formation of others regio-isomers (4 and 5) but 3 was still in majority. The isolated 
yield of 3, 4 and 5 were 48.0 %, 2.8 % and 1.5 %, respectively. Analytical TLC of the reactional 
medium after 24 h, 48 h and 80 h showed the presence of compound 3, the mixture of 3 and 4, 
and the mixture of 3, 4 and 5 respectively. The regioselectivity of this allylic oxidation on 
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cholesterol may be due to the effect of OH-3 group. 
The 1H NMR and 13C NMR data of compound 3 were in agreement with the reported values 
of 5-cholestene-3β,4β-diol [8]. Indeed, the multiplicity of H-3 signal changing from multiplet to 
doublet triplet (dt), the chemical shift values of H-4 and C-4 (δH 4.13/δC 77.3 ppm) and HMBC 
correlations between H-4 to C-2 and C-3 confirmed that the oxidative reaction occurred at C-4. 
In the case of compound 4, the 1H NMR spectrum showed the presence of three protons linked 
to oxygenated carbons at δH 3.60 (H-3), 3.94 (H-7) and 4.18 (H-4). In addition, the signal of H-6 
(δH 5.87) clearly appeared as a doublet with J = 5.0 Hz. The 13C NMR spectrum showed three 
signals at δC 76.9, 72.1 and 65.3 which are assigned to three oxygenated carbons belonging to C-
4, C-3 and C-7, respectively. Thus, by combination of 1D and 2D NMR data, compound 4 was 
identified as 7-hydroxylated product of 3. Similarly, compound 5 was determined as 7-
hydroxylated product of cholesterol. According to the other reported articles about this reaction 
on sterols, all products contained hydroxyl groups in 4- or/and 7-β position by the characteristic 
chemical shift values and multiplicities of oxygenated CH groups [10]. 
 
Figure 1. Reagents and conditions: (i): BH3.THF, H2O2, NaOH, 0 oC then rt, 1h (1: 71 %, 2: 9 %);                 
(ii): SeO2, dioxane, H2O, 80 oC, 48 h (3: 50 %, 4: 3,5 %, 5: 2%); (iii): 4 % OsO4/H2O, NMO, reflux,             
48 h (6: 74 %, 7: 78 %); (iv): 1. HCOOH 88 %, THF/H2O2, 12h, 2. KOH 3 % in MeOH (8: 75 %). 
Cis-dihydroxylation on cholesterol using OsO4/NMO yielded 6 which was elucidated as 5,6-
cis-α-dihydroxyl cholesterol derivative by 1D and 2D NMR spectra. The 13C NMR spectrum 
showed the presence of two oxygenated carbon signals at δC 76.7 (C-5) and 70.6 (C-6). The 
NOESY spectrum showed the cross-peak between CH3-19 and H-6, indicating the H-6 in β 
position. Therefore, the OH-6 and thus OH-5 groups were in α position. 
While treating compound 3 with OsO4/NMO using the same procedure as above, the 
tetrahydroxyl product 7 was obtained with 5,6-OH in α position. The NOESY spectrum of 7 
  
Dinh Thi Ha, Doan Lan Phuong, Pham Quoc Long, Ngo Dai Quang, Tran Thi Thu Thuy 
 
472 
showed correlation between H-6 and CH3-19, indicating the H-6 in β position. Therefore, the 
OH-6 and OH-5 groups were in α position.  
The formation of only 5α,6β-diol isomer 8 (75 %) was observed when oxidation of 
cholesterol using performic acid (HCOOH/H2O2). Although, some previous works [11] reported 
that a mixture of α,β-diol or β,α-diol can be obtained from other ∆5 sterols when using this 
reagent. The 5β,6α-diol isomer with 5-OH group in the same side with CH3-19 was not favorable 
owing to steric effect. The 1H and 13C NMR spectra of compound 8 indicated the successful 
dihydroxylation on the double bond with the presence of an oxygenated methine at δH 3.49 (H-6) 
and two carbons at δC 75.7 (C-5) and 76.0 (C-6). The NOESY spectrum showed no interaction 
between CH3-19 and H-6, indicating that H-6 and OH-5 group was in α position. Therefore, the 
OH-6 group was in β position. This compound was previously isolated from marine organisms, 
but with a trace amount as Damiriana hawaiiana sponges, or from the purple coral Muriceosis 
flavida distributed in the East Sea. Compound 8 promotes the apoptosis of A549 lung cancer 
cells, MG63 malignant bone cancer, and HT-29 human colon cancer [12]. This is the first time 
compound 8 was synthesized from cholesterol after one step by using performic acid as 
oxidative agent. 
The cytotoxic activity on Hep-G2 cell line (hepatocellular carcinoma) and T98 cell line 
(glioblastoma) of all compounds were evaluated. Compounds 2, 4 and 8 exhibited strong 
cytotoxicity against Hep-G2 cell with IC50 values of 11.59, 11.89 and 6.87 µM, respectively. In 
addition, compound 8 exhibited a quite strongly cytotoxicity against T98 cell line with IC50 = 
2.28 µM. 
4. CONCLUSIONS 
Eight polyhydroxyl derivatives of cholesterol with 2-4 hydroxyl groups were prepared after 
1-2 steps by using simple and effective procedures. The number, position and stereo 
configuration of adding hydroxyl groups vary depending on used oxidative agents. This is the 
first time compound 8 was prepared by the synthetic pathway from cholesterol as starting 
material. Compounds 2, 4 and 8 were found potential for cytotoxic activities on Hep-G2 and T98 
cancer cell lines. 
Acknowledgments. This work was supported financially by the Vietnam Academy of Science and 
Technology under project VAST.TĐ.DLB.05/16-18. We also thank to Dr. Lee Jae Wook (KIST 
Gangneung) and Dr. Tran Thi Hong Ha (INPC) for their cytotoxic test on T98 and Hep-G2 cell lines. 
REFERENCES  
1. Gaurdiola F., Codony R., Addis P. B., Rafecas M., Boatella J. – Biological effects of 
oxysterols: current status, Food. Chem. Toxic. 34 (1996) 193-211. 
2. Meier T., Magyar J. P., Courdier-Fruh I. – Use of Non-Glucocorticoid Steroids for the 
Treatment of Muscular Dystrophy, Eur. Pat. WO A1 (2006, 2006/7910. 
3. Kenny O., O’Callaghan Y., O’Connell N. M., McCarthy F. O., Maguire A. R., O’Brien N. 
M. – Oxidized derivaties of dihydro-brassicasterol: cytotoxic and apoptotic potential in 
U937 and HepG2 cells, J. Agric. Food. Chem. 60 (2012) 5952-5961. 
4. Maud V., Sandrine S. P., Marc P. – One step synthesis of 6-oxo-cholestan-3β,5α-diol. 
Biochem. And Biophys,  Res. Commun. 446 (2014) 782-785. 
  
Synthesis and cytotoxicity of polyhydroxylated cholesterol derivatives  
 
473 
5. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., 
Bokesch H., Kenney S., Boyd M. R. - New colorimetric cytotoxicity assay for anticancer 
agents, Eur. J. Cancer 27 (1991) 1162–1168. 
6. Likhitayawuid K., Angerhofer C. K. - Cytotoxic and antimalarial bisbenzylisoquinoline 
alkaloids from Sephania evecta, J. Nat. Prod. 56 (1) (1993) 30-38. 
7. Younus M. S., Bernard M. T., Carl D. - 5α-pregn-9(11)-ene-3β,6α -diol-20-one and 5α-
cholesta-9(11),20(22)-diene-3β,6α-diol-23-one. Two novel steroids from the starfish 
Acanthaster planc, J. Am. Chem. Soc. 94 (9) (1972) 3278-3280. 
8. Eunsook M., Taeyoung C. – An Efficient 4β-Hydroxylation of Steroidal 5-en-3β-ols and 
1,4-Conjugation of Steroidal 4-en-3-ones Using SeO2 Oxidation, Bull. Korean Chem. Soc. 
30 (1) (2009) 245-248. 
9. Dinh T. Ha, Doan L. Phuong, Tu T. K. Trang, Pham Q. Long, Ngo D. Quang, Manobjyoti 
B., Tran T. T. Thuy – Synthesis of polyhydroxysteroid from diosgenin, Journal of Science 
and Technology 54 (2B) (2016) 222-229. 
10. Jian G. C, Cui W. L., Long M. Z., Jing Y. S. – Synthesis of polyhydroxysterols (III): 
synthesis and structural elucidation of 24-methylenecholest-4-en-3β,6α-diol, Steroids 67 
(2002) 1015-1019. 
11. Weigang L., Longmei Z., Jingyu S. – Synthesis of polyhydroxysterols (IV): synthesis of 
24-methylene-cholesta-3β,5α,6β,19-tetrol, a cytotoxic natural hydroxylated sterol, 
Steroids 69 (2004) 445-449. 
12. Tao-Fang L., Xin L., Hua T., Min-Min Z., Pan W., Peng S., Zhi-Yong L., Zeng-Lei W., 
Ling L.,  Yao-Cheng R., Tie-Jun L., Wen Z. – 3β,5α,6β-Oxygenated sterols from the 
South China Sea gorgonian Muriceopsis flavida and their tumor cell growth inhibitory 
activity and apoptosis-inducing function, Steroids 78 (2013) 108-114. 
 
